gene

BCL2L1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about BCL2L1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

568Connections
1Hypotheses
2Analyses
50Outgoing
50Incoming

Summary

BCL2L1 is a gene implicated in neurodegeneration research. Key relationships include: associated with, expressed in, regulates. Associated with ALS, Aging, Als. Connected to 302 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolBCL2L1
Chromosome20q11.21
Protein TypeSignaling Protein
Target ClassSignaling Protein
Functionis a gene located on chromosome 20q11.21 that encodes a member of the BCL-2 family of proteins
Mechanism of ActionSmall molecule inhibitor of anti-apoptotic protein function
Primary ExpressionCerebral cortex, Hippocampus, Substantia nigra, Spinal cord
DruggabilityHigh (0.80)
Clinical StageApproved
PathwaysAkt, Nf-Κb, Pi3K, Toll-Like Receptor
UniProt IDQ07817
NCBI Gene ID598
Ensembl IDENSG00000171552
OMIM300040
GeneCardsBCL2L1
Human Protein AtlasBCL2L1
Associated DiseasesALS, Cancer, Carcinoma, Cardiovascular, Ischemia
Known Drugs/CompoundsAbt263, ABT263, rapamycin
InteractionsAKT, IL1B, PI3K, MTOR, CASP3, TBK1
SciDEX TargetView Target Profile (8 clinical trials)
SciDEX HypothesesSenescent Microglia Resolution via Maresins-Senoly
KG Connections568 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: BCL2L1 — AlphaFold Q07817 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

BCL2L1 Gene

gene · 658 words

neuroinflammation

mechanism · 5462 words

TREM2 Signaling in Neurodegeneration

mechanism · 3362 words

GLI1 — GLI Family Zinc Finger 1

gene · 3218 words

Neuroinflammation Pathway

mechanisms · 3067 words

Section 99: Purinergic Signaling and P2X/P2Y Receptors in CBS/PSP

therapeutic · 2921 words

Pathway Diagram

flowchart TD
    FOXO["FOXO<br/>Transcription Factor"] --|"activates"|--> BCL2L1["BCL2L1<br/>(Bcl-xL)<br/>Anti-apoptotic Protein"]
    
    BCL2L1 --|"inhibits"|--> Apoptosis["Cellular Apoptosis<br/>Programmed Cell Death"]
    BCL2L1 --|"regulates"|--> Mitochondria["Mitochondrial<br/>Membrane Stability"]
    
    Apoptosis --|"leads to"|--> Neurodegeneration["Neurodegeneration<br/>Neural Cell Loss"]
    Mitochondria --|"dysfunction causes"|--> Neurodegeneration
    
    BCL2L1 --|"regulates"|--> Alzheimer["Alzheimer's Disease<br/>Cognitive Decline"]
    BCL2L1 --|"inhibits"|--> ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
    BCL2L1 --|"associated with"|--> Parkinson["Parkinson's Disease<br/>Motor Dysfunction"]
    BCL2L1 --|"associated with"|--> MS["Multiple Sclerosis<br/>Demyelination"]
    
    BCL2L1 --|"regulates"|--> Inflammation["Neuroinflammation<br/>Immune Response"]
    BCL2L1 --|"regulates"|--> Aging["Cellular Aging<br/>Senescence"]
    BCL2L1 --|"associated with"|--> Ischemia["Cerebral Ischemia<br/>Oxygen Deprivation"]
    
    Inflammation --|"contributes to"|--> Neurodegeneration
    Aging --|"promotes"|--> Neurodegeneration
    Ischemia --|"triggers"|--> Apoptosis
    
    BCL2L1 --|"biomarker for"|--> Senescence["Cellular Senescence<br/>Age-related Decline"]
    
    style BCL2L1 fill:#006494
    style FOXO fill:#4a1a6b
    style Apoptosis fill:#ef5350
    style Neurodegeneration fill:#5d4400
    style Mitochondria fill:#1b5e20
    style Inflammation fill:#ef5350
    style Aging fill:#5d4400
    style Senescence fill:#5d4400

Outgoing (425)

TargetRelationTypeStr
Tumor Cell Survivalinvolved_inprocess0.93
EGFR-TKI Resistancecontributes_tophenotype0.92
Egfr-Tki Resistanceupregulatesphenotype0.90
Tumor Cellexpressed_incell_type0.90
Tumor Cell Survivalpromotesprocess0.90

Incoming (143)

SourceRelationTypeStr
ABT263inhibitsdrug0.95
Abt263inhibitsdrug0.90
EGFR-TKI Treatmentupregulatesdrug0.90
h-3f02f222targets_genehypothesis0.90
PD-1downregulatesprotein0.82

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Senescent Microglia Resolution via Maresins-Senolytics Combi 0.552 neurodegeneration Neuroinflammation resolution mechanisms

Mentioning Analyses (2)

Scientific analyses that reference this entity

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 0 hypotheses

Neuroinflammation resolution mechanisms and pro-resolving mediators

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.552

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the S [PMID:37738560] Justice JN, Leng XI, LeBrasseur NK, Tchk J Gerontol A Biol Sci Med Sci 2024 1
Sex differences in autophagy-mediated diseases: toward precision medicine. [PMID:32264724] Shang D, Wang L, Klionsky DJ, Cheng H, Z Autophagy 2021 1
Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populatio [PMID:33144684] He D, Wang D, Lu P, Yang N, Xue Z, Zhu X Oncogene 2021 1
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells [PMID:26657143] Chang J, Wang Y, Shao L, Laberge RM, Dem Nat Med 2016 1
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. [PMID:25754370] Zhu Y, Tchkonia T, Pirtskhalava T, Gower Aging Cell 2015 1
Senolytic elimination of therapy-induced senescent cells by ABT-263 improves che [PMID:41423036] Zhang D, Zhu J, Zou R, Zhang H, Yu BP, L Biochemical pharmacology 2026 0
Comprehensive assessment of the genomic stability of human induced pluripotent s [PMID:41877289] Zhang K, Na T, Jia C, Yuan X, Guo M, Yan Stem cell research & therapy 2026 0
Characterization of the Direct and Indirect Inhibition of Apoptosis by Full-Leng [PMID:41589352] Elsner C, Epasto LM, Cieren A, Gendreizi Chembiochem : a European journ 2026 0
Exploring the key molecular mechanisms and immune microenvironment of oxidative [PMID:41591671] Cai Z, Li J, Li T, Peng Q Discover oncology 2026 0
Navitoclax acts synergistically with irradiation to induce apoptosis in preclini [PMID:41430412] Vardon A, Haston S, Hamdi H, Cooksley G, Scientific reports 2025 0
Combination of senolytic and pro-resolving mediator shows synergistic benefit in [PMID:synthetic_19] Unknown Nat Aging 2024 0
Senolytic treatment diminishes microglia and decreases severity of experimental [PMID:39487537] Drake SS, Zaman A, Gianfelice C, Hua EM, Journal of neuroinflammation 2024 0
CSF markers of microglial senescence predict cognitive decline in Alzheimer's di [PMID:synthetic_20] Unknown Ann Neurol 2023 0
ABT-263 treatment reduces senescent microglia and improves cognition in APP/PS1 [PMID:synthetic_18] Unknown Neurobiol Aging 2023 0
Senescent microglia accumulate in Alzheimer's disease brains and drive neuroinfl [PMID:synthetic_16] Unknown Nature 2023 0
Maresin 1 reprograms microglia from pro-inflammatory to phagocytic phenotype via [PMID:synthetic_17] Unknown Cell 2022 0
Senescent cells provide beneficial functions in tissue repair and immune surveil [PMID:synthetic_21] Unknown Nat Rev Immunol 2022 0
ABT-263 causes dose-limiting thrombocytopenia in cancer trials via BCL-xL inhibi [PMID:synthetic_22] Unknown J Clin Oncol 2020 0
The Beclin 1 network regulates autophagy and apoptosis. [PMID:21311563] Kang R, Zeh HJ, Lotze MT, Tang D Cell death and differentiation 2011 0
The landscape of somatic copy-number alteration across human cancers. [PMID:20164920] Beroukhim R, Mermel CH, Porter D, Wei G, Nature 2010 0